USA flag logo/image

An Official Website of the United States Government

Company Information:

Company Name:
LIFECELL CORPORATION
Address:
LIFECELL CORPORATION
1 MILLENIUM WAY
SOMERVILLE, NJ 08876
Phone:
(908) 947-1100
URL:
N/A
EIN:
760172936
DUNS:
N/A
Number of Employees:
N/A
Woman-Owned?:
No
Minority-Owned?:
No
HUBZone-Owned?:
No

Commercialization:

Has been acquired/merged with?:
N/A
Has had Spin-off?:
N/A
Has Had IPO?:
N/A
Year of IPO:
N/A
Has Patents?:
N/A
Number of Patents:
N/A
Total Sales to Date $:
$ 0.00
Total Investment to Date $
$ 0.00
POC Title:
N/A
POC Name:
N/A
POC Phone:
N/A
POC Email:
N/A
Narrative:
N/A

Award Totals:

Program/Phase Award Amount ($) Number of Awards
SBIR Phase I $932,410.00 13
SBIR Phase II $3,642,048.00 6

Award List:

HUMAN RED BLOOD CELL FREEZING WITH AND WITHOUT METABOLIZABLE CRYOPRESERVATIVES MOLECULAR DISTILLATION DRYING STORAGE AND...

Award Year / Program / Phase:
1989 / SBIR / Phase II
Award Amount:
$500,000.00
Agency / Branch:
DOD / NAVY
Principal Investigator:
Dr S Randolph May
Abstract:
A goal of erythrocyte hypothermic preservation is to develop a nontoxic, metabolizable cryoprotectant to decrease the inherent cytotoxicity and to minimize or eliminate the costly and time consuming cell washing procedures postthaw. we propose that cryoprotectants be eliminated or used at minimal… More

PRESERVATION OF DERMIS FOR IN SITU SKIN RECONSTITUTION

Award Year / Program / Phase:
1989 / SBIR / Phase I
Award Amount:
$50,000.00
Agency:
HHS
Principal Investigator:
Abstract:
The aim of this research is to develop technology and devices for the preservation and drying of the dermal portion of human skin so that it may be stored at room temperature for later use in transplantation onto denuded, wounded, or burned areas of patients' body surfaces. once rehydrated and… More

FREEZING DRYING AND REHYDRATION OF MAMMALIAN CELLS

Award Year / Program / Phase:
1989 / SBIR / Phase I
Award Amount:
$50,000.00
Agency:
HHS
Principal Investigator:
Abstract:
N/a

HUMAN RED BLOOD CELL FREEZING WITH AND WITHOUT METABOLIZABLE CRYOPRESERVATIVES MOLECULAR DISTILLATION DRYING STORAGE AND...

Award Year / Program / Phase:
1989 / SBIR / Phase I
Award Amount:
$50,000.00
Agency / Branch:
DOD / NAVY
Principal Investigator:
Dr S Randolph May
Abstract:
N/a

FREEZING DRYING AND REHYDRATION OF MAMMALIAN CELLS

Award Year / Program / Phase:
1990 / SBIR / Phase II
Award Amount:
$500,000.00
Agency:
HHS
Principal Investigator:
Abstract:
To demonstrate that cultured mammalian cells can be frozen, dried, rehydrated, and revivified, four cell lines were chosen for experiments that will determine: (1) the optimum method of cell vitrification (freezing without ice crystals)and whether cryoprotection is necessary, (2) whether drying… More

PRESERVATION OF LOW-DAMAGE ALLOGENEIC HEART VALVES

Award Year / Program / Phase:
1990 / SBIR / Phase I
Award Amount:
$49,000.00
Agency:
HHS
Principal Investigator:
S Randolph May
Abstract:
N/a

PRESERVATION OF LOW-DAMAGE ALLOGENEIC HEART VALVES

Award Year / Program / Phase:
1991 / SBIR / Phase II
Award Amount:
$500,000.00
Agency:
HHS
Principal Investigator:
S Randolph May
Abstract:
The long-term objective of this research is to develop technology and devices for the preservation and drying of porcine bioprosthetic or human allograft heart valves that allow storage in a nonfrozen state. once rehydrated, the potential advantages of such valves would be longer and moreconvenient… More

DRY PRESERVATION OF TRANSPLANTABLE VEINS

Award Year / Program / Phase:
1991 / SBIR / Phase I
Award Amount:
$49,999.00
Agency:
HHS
Principal Investigator:
Nag, Abhijit , Principal Investigator
Abstract:
The long-term objective of this research is to develop technology and devices for the cryopreservation and drying of human allograft saphenous veins and ultimately bioprosthetic heterograft vessels which allow storage in a non-frozen state (4oc - 22oc). veins will be preserved by vitrification with… More

PROLONGED PRESERVATION OF HUMAN PLATELETS FOR COMBAT CASUALTY CARE

Award Year / Program / Phase:
1991 / SBIR / Phase I
Award Amount:
$50,000.00
Agency / Branch:
DOD / ARMY
Principal Investigator:
Stephen A Livesey Md , Principal Investigator
Abstract:
N/a

PROLONGED PRESERVATION OF HUMAN PLATELETS FOR COMBAT CASUALTY CARE

Award Year / Program / Phase:
1993 / SBIR / Phase II
Award Amount:
$741,232.00
Agency / Branch:
DOD / ARMY
Principal Investigator:
Stephen A Livesey Md , Principal Investigator
Abstract:
The aim of this proposal is to develop protocols for the long-tarts cryopreservation of human platelets for transfusion. optimization of platelet isolation and cryopreservation will be combined with specific modulation of stimulus response coupling mechanisms in the platelet. the effectiveness of… More

RECONSTITUTED SKIN

Award Year / Program / Phase:
1994 / SBIR / Phase I
Award Amount:
$65,000.00
Agency:
NSF
Principal Investigator:
Stephen A Livesey
Abstract:
N/a

RECONSTITUTED SKIN

Award Year / Program / Phase:
1996 / SBIR / Phase II
Award Amount:
$300,000.00
Agency:
NSF
Principal Investigator:
Stephen A Livesey
Abstract:
The current accepted treatment for replacing full-thickness skin lost to injury or ulceration is to graft healthy, split-thickness skin (ssg) from an uninjured area of the body to the wound site. treatment is typically complicated by pain and trauma to the donor site and scarring and contracture at… More

DirectlyTransfusable Cryopreserved Red Blood Cells

Award Year / Program / Phase:
1998 / SBIR / Phase I
Award Amount:
$99,884.00
Agency / Branch:
DOD / OSD
Principal Investigator:
Jerome Connor, Ph.d.
Abstract:
This program is designed to establish the feasibility of developing a directly transfusable cryopreserved Red Blood cell (RBC) product. The approach of Lifecell's program is to utilize oxidative control and specific biocompatible water-structuring molecules to induce the formulation of… More

Frozen Storage of Human Platelets with Directly Transfusable Cryoprotectants

Award Year / Program / Phase:
1999 / SBIR / Phase I
Award Amount:
$69,852.00
Agency / Branch:
DOD / ARMY
Principal Investigator:
Jerome Connor PhD
Abstract:
Not Available Mission Research Corporation (MRC) proposes to develop and demonstrate a solution to the single event effects (SEE) problems which result in data loss in deep submicron microcircuits used in space environments. We describe a unique hardening technique, which we refer to as a … More

N/A

Award Year / Program / Phase:
2000 / SBIR / Phase I
Award Amount:
$100,000.00
Agency:
HHS
Principal Investigator:
David J. Mcquillan
Abstract:
N/a

BIGLYCAN AS A THERAPEUTIC FOR MUSCULAR DYSTROPHY

Award Year / Program / Phase:
2002 / SBIR / Phase I
Award Amount:
$100,313.00
Agency:
HHS
Principal Investigator:
Abstract:
DESCRIPTION (provided by applicant): The overall goal of this proposal is to use animal models to test the efficacy of biglycan as a protein therapeutic for muscular dystrophy. Duchenne's muscular dystrophy (DMD) is a heritable disease that affects approximately 1 in 3,500 boys. These children are… More

Biglycan as a Therapeutic for Muscular Dystrophy

Award Year / Program / Phase:
2003 / SBIR / Phase II
Award Amount:
$1,100,816.00
Agency:
HHS
Principal Investigator:
Abstract:
DESCRIPTION (provided by applicant): The overall goal of this proposal is to use animal models to test the efficacy of biglycan as a protein therapeutic for muscular dystrophy. Duchenne's muscular dystrophy (DMD) is a heritable disease that affects approximately 1 in 3,500 boys. These children are… More

Biochemical Stabilization for Freeze Dried Platelets

Award Year / Program / Phase:
2003 / SBIR / Phase I
Award Amount:
$98,050.00
Agency:
HHS
Principal Investigator:
Abstract:
DESCRIPTION (provided by applicant): The focus of this Phase I proposal is to assess the feasibility of applying our platform of cellular biochemical stabilization with unique freezing and drying engineering design to the goal of generating freeze-dried therapeutic cells. Specifically, this program… More

Gene Activated Cymetra for Repair of Orthopaedic Tissue

Award Year / Program / Phase:
2003 / SBIR / Phase I
Award Amount:
$100,312.00
Agency:
HHS
Principal Investigator:
Abstract:
DESCRIPTION (provided by applicant): The repair of damaged articular cartilage is problematic due to the limited regenerative potential of this tissue. Current procedures used for the repair of articular cartilage may provide symptomatic relief, but are flawed in that no single treatment results… More